Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Decreases By 50.2%

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 116,400 shares, a drop of 50.2% from the March 15th total of 233,600 shares. Approximately 6.5% of the shares of the company are short sold. Based on an average daily volume of 85,100 shares, the days-to-cover ratio is currently 1.4 days.

BioNexus Gene Lab Stock Up 1.5 %

Shares of BGLC stock traded up $0.04 during mid-day trading on Wednesday, hitting $2.69. The stock had a trading volume of 65,212 shares, compared to its average volume of 265,311. The company’s 50-day simple moving average is $3.14 and its 200-day simple moving average is $3.32. BioNexus Gene Lab has a fifty-two week low of $2.01 and a fifty-two week high of $10.00.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.